A Traditional Herbal Formula Xianlinggubao for Pain Control and Function Improvement in Patients with Knee and Hand Osteoarthritis: A Multicenter, Randomized, Open-Label, Controlled Trial

Fei Wang, Lei Shi, Yaonan Zhang, Kunzheng Wang, Fuxing Pei, Hanmin Zhu, Zhanjun Shi, Tianzun Tao, Zhihua Li, Ping Zeng, Xiaobing Wang, Quan Ji, Ling Qin, Qingxun Xue, Fei Wang, Lei Shi, Yaonan Zhang, Kunzheng Wang, Fuxing Pei, Hanmin Zhu, Zhanjun Shi, Tianzun Tao, Zhihua Li, Ping Zeng, Xiaobing Wang, Quan Ji, Ling Qin, Qingxun Xue

Abstract

Evidence of efficacy of a traditional herbal formula Xianlinggubao (XLGB) for treatment of osteoarthritis (OA) is limited. The present study was designed to evaluate the efficacy of XLGB in the management of patients with knee and hand OA. This was a multicenter, stratified, open-label, randomized controlled trial conducted at six centers in China. People aged 40 or above, diagnosed with OA of the knee or hand, were randomly assigned to the XLGB treatment group or watchful waiting control group. Main outcome measures were the changes in the numeric pain rating scales (NPRS) and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) or the Australian/Canadian Osteoarthritis Hand Index (AUSCAN) scores, from baseline to 6 months. In total 534 patients (272 to XLGB and 262 to control group) received interventions. Participants in the XLGB group exhibited significant improvement in NPRS (P < 0.001) and WOMAC score (P < 0.001) or AUSCAN score (P < 0.001) compared to control group. Treatment with XLGB at current regime significantly reduced pain and improved function of the knee and hand in patients with OA over a 6-month period, implying that XLGB could be suggested as an alternative treatment for patients with knee or hand OA.

Figures

Figure 1
Figure 1
Flow diagram of clinical trial design.

References

    1. Woolf A. D., Pfleger B. Burden of major musculoskeletal conditions. Bulletin of the World Health Organization. 2003;81(9):646–656.
    1. Valderrabano V., Steiger C. Treatment and prevention of osteoarthritis through exercise and sports. Journal of Aging Research. 2011;2011:6. doi: 10.4061/2011/374653.374653
    1. Pelletier J.-P., Martel-Pelletier J., Abramson S. B. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis & Rheumatism. 2001;44(6):1237–1247. doi: 10.1002/1529-0131(200106)44:6<1237::AID-ART214>;2-F.
    1. McAlindon T. E., Bannuru R. R., Sullivan M. C., et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage. 2014;22(3):363–388. doi: 10.1016/j.joca.2014.01.003.
    1. Centre N. C. G. London: National Institute for Health and Care Excellence. 2014. Osteoarthritis: Care and Management in Adults.
    1. Brown G. A. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. Journal of the American Academy of OrthopaedicSurgeons . 2013;21(9):577–579. doi: 10.5435/jaaos-21-09-577.
    1. Zhang W., Moskowitz R. W., Nuki G., et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16(2):137–162.
    1. Tramer M. R., Moore R. A., Reynolds D. J. M., McQuay H. J. Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use. PAIN. 2000;85(1-2):169–182. doi: 10.1016/s0304-3959(99)00267-5.
    1. Makris U. E., Abrams R. C., Gurland B., Reid M. C. Management of persistent pain in the older patient: A clinical review. Journal of the American Medical Association. 2014;312(8):825–836. doi: 10.1001/jama.2014.9405.
    1. Cameron M., Chrubasik S. Oral herbal therapies for treating osteoarthritis. The Cochrane Database of Systematic Reviews. 2014;5D002947
    1. Chen F.-P., Chang C.-M., Hwang S.-J., Chen Y.-C., Chen F.-J. Chinese herbal prescriptions for osteoarthritis in Taiwan: analysis of national health insurance dataset. BMC Complementary and Alternative Medicine. 2014;14, article 91 doi: 10.1186/1472-6882-14-91.
    1. Xie X.-H., Wang X.-L., Yang H.-L., Zhao D.-W., Qin L. Steroid-associated osteonecrosis: Epidemiology, pathophysiology, animal model, prevention, and potential treatments (an overview) Journal of Orthopaedic Translation. 2015;3(2):58–70. doi: 10.1016/j.jot.2014.12.002.
    1. Zhang G., Qin L., Shi Y. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: A 24-month randomized, double-blind and placebo-controlled trial. Journal of Bone and Mineral Research. 2007;22(7):1072–1079. doi: 10.1359/jbmr.070405.
    1. Zhu H. M., Qin L., Garnero P., et al. The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis. Osteoporosis International. 2012;23(4):1317–1327. doi: 10.1007/s00198-011-1577-2.
    1. Zhang G., Qin L., Sheng H., et al. Epimedium-derived phytoestrogen exert beneficial effect on preventing steroid-associated osteonecrosis in rabbits with inhibition of both thrombosis and lipid-deposition. Bone. 2007;40(3):685–692. doi: 10.1016/j.bone.2006.10.026.
    1. Cheng Y., Liu Y., Wang H., et al. A 26-week repeated dose toxicity study of Xian-ling-gu-bao in Sprague-Dawley rats. Journal of Ethnopharmacology. 2013;145(1):85–93. doi: 10.1016/j.jep.2012.09.055.
    1. Zhen G., Wen C., Jia X., et al. Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nature Medicine. 2013;19:704–712. doi: 10.1038/nm.3143.
    1. Wen C., Lu W. W., Chiu K. Y. Importance of subchondral bone in the pathogenesis and management of osteoarthritis from bench to bed. Journal of Orthopaedic Translation. 2014;2(1):p. 10. doi: 10.1016/j.jot.2014.03.003.
    1. de Silva V., El-Metwally A., Ernst E., Lewith G., Macfarlane G. J. Evidence for the efficacy of complementary and alternative medicines in the management of osteoarthritis: A systematic review. Rheumatology. 2011;50(5):911–920. doi: 10.1093/rheumatology/keq379.keq379
    1. Altman R., Asch E., Bloch D. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis & Rheumatology. 1986;29(8):1039–1052. doi: 10.1002/art.1780290816.
    1. Altman R., Alarcón G., Appelrouth D., et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis & Rheumatology. 1990;33(11):1601–1610. doi: 10.1002/art.1780331101.
    1. Kellgren J. H., Lawrence J. S. Radiological assessment of osteo-arthrosis. Annals of the Rheumatic Diseases. 1957;16(4):494–502. doi: 10.1136/ard.16.4.494.
    1. Downie W. W., Leatham P. A., Rhind V. M., Wright V., Branco J. A., Anderson J. A. Studies with pain rating scales. Annals of the Rheumatic Diseases. 1978;37(4):378–381. doi: 10.1136/ard.37.4.378.
    1. Bellamy N., Buchanan W. W., Goldsmith C. H., Campbell J., Stitt L. W. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. The Journal of Rheumatology. 1988;15(12):1833–1840.
    1. Bellamy N., Campbell J., Haraoui B., et al. Dimensionality and clinical importance of pain and disability in hand osteoarthritis: Development of the Australian/Canadian (AUSCAN) osteoarthritis hand index. Osteoarthritis and Cartilage. 2002;10(11):855–862. doi: 10.1053/joca.2002.0837.
    1. Dai Y., Tu F.-J., Yao Z.-H., et al. Rapid identification of chemical constituents in traditional Chinese medicine Fufang preparation Xianling Gubao capsule by LC-linear ion trap/orbitrap mass spectrometry. American Journal of Chinese Medicine. 2013;41(5):1181–1198. doi: 10.1142/S0192415X13500808.
    1. Pham T., van der Heijde D., Altman R. D., et al. OMERACT-OARSI initiative: osteoarthritis research society international set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis and Cartilage. 2004;12(5):389–399. doi: 10.1016/j.joca.2004.02.001.
    1. Clegg D. O., Reda D. J., Harris C. L., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. The New England Journal of Medicine. 2006;354(8):795–808.
    1. Hochberg M. C., Martel-Pelletier J., Monfort J., et al. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: A multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Annals of the Rheumatic Diseases. 2016;75(1, article A6):37–44. doi: 10.1136/annrheumdis-2014-206792.
    1. Wang X., Wei S., Liu T., et al. Effectiveness, medication patterns, and adverse events of traditional Chinese herbal patches for osteoarthritis: a systematic review. Evidence-Based Complementary and Alternative Medicine. 2014;2014:17. doi: 10.1155/2014/343176.343176
    1. Wang X., He Y., Guo B., et al. In vivo screening for anti-osteoporotic fraction from extract of herbal formula xianlinggubao in ovariectomized mice. PLoS ONE. 2015;10(2) doi: 10.1371/journal.pone.0118184.e0118184
    1. Geng J.-L., Dai Y., Yao Z.-H., et al. Metabolites profile of Xian-Ling-Gu-Bao capsule, a traditional Chinese medicine prescription, in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry analysis. Journal of Pharmaceutical and Biomedical Analysis. 2014;96:90–103. doi: 10.1016/j.jpba.2014.03.024.
    1. Wang P., Zhang F., He Q., et al. Flavonoid compound icariin activates hypoxia inducible factor-1α in chondrocytes and promotes articular cartilage repair. PLoS ONE. 2016;11(2) doi: 10.1371/journal.pone.0148372.e0148372
    1. Sun P., Liu Y., Deng X., et al. An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis. Phytomedicine. 2013;20(11):975–979. doi: 10.1016/j.phymed.2013.04.019.
    1. Jung H. W., Jung J. K., Son K. H., et al. Inhibitory effects of the root extract of Dipsacus asperoides C.Y. Cheng et al on collagen-induced arthritis in mice. Journal of Ethnopharmacology. 2012;139(1):98–103. doi: 10.1016/j.jep.2011.10.020.
    1. Wojdasiewicz P., Poniatowski Ł. A., Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators of Inflammation. 2014;2014:19. doi: 10.1155/2014/561459.561459
    1. de Lange-Brokaar B. J. E., Ioan-Facsinay A., van Osch G. J. V. M., et al. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis and Cartilage. 2012;20(12):1484–1499. doi: 10.1016/j.joca.2012.08.027.
    1. Baek G.-H., Jang Y.-S., Jeong S.-I., et al. Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products. Inflammation. 2012;35(4):1232–1241. doi: 10.1007/s10753-012-9433-x.
    1. Gao D., Mendoza A., Lu S., Lawrence D. A. Immunomodulatory Effects of Danshen (Salvia miltiorrhiza) in BALB/c Mice. ISRN Inflamm. 2012;2012954032
    1. Jang S.-I., Jeong S.-I., Kim K.-J., et al. Tanshinone IIA from Salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF-α, IL-1β and IL-6 in activated RAW 264.7 Cells. Planta Medica. 2003;69(11):1057–1059. doi: 10.1055/s-2003-45157.
    1. Zhou J., Xu G., Yan J., et al. Rehmannia glutinosa (Gaertn.) DC. polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice. Journal of Ethnopharmacology. 2015;164:229–238. doi: 10.1016/j.jep.2015.02.026.
    1. Liu C.-L., Cheng L., Ko C.-H., et al. Bioassay-guided isolation of anti-inflammatory components from the root of Rehmannia glutinosa and its underlying mechanism via inhibition of iNOS pathway. Journal of Ethnopharmacology. 2012;143(3):867–875. doi: 10.1016/j.jep.2012.08.012.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren